> FDA issues warning over risks of off-brand weight loss drugs
FDA issues warning over risks of off-brand weight loss drugs
Clip ID 2515979
Clearance
Add to
Share
Add to Review Link
By Request
By Request assets are not available for immediate purchase.
This content has not been pre-checked for copyright.
Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us
Description
Off-brand, compounded versions of drugs like Ozempic and Wegovy are growing fast —and with them, the chance of complications.